Clinical Trial Update: Lacidipine in Medical Practice in Patients With Mild to Moderate Essential Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial of Lacidipine in patients with mild to moderate essential hypertension has completed. This document provides a status update on the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Lacidipine (Lacidipine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 3 | Status: COMPLETED